Declan joined Vitro Software in 2014 and is responsible for managing the financial oversight of the company, he has over 16 years’ experience in senior finance and executive roles in the healthcare and biotechnology industry. As Executive Vice President & CFO of INAMED Corporation (IMDC: NASDAQ) based in California, Declan was instrumental in executing the $3.3 billion sale of INAMED Corporation to Allergan, Inc. (AGN: NYSE) in April 2006. Subsequent to the sale of INAMED, Declan joined Fibrocell Science, Inc. (NYSE MKT: FCSC) where he spent eight years, there Declan was pivotal in the growth of Fibrocell from a small, aesthetics-focused entity to an NYSE MKT listed company focused on developing first-in class treatments for rare and serious skin and connective tissue diseases with high unmet needs. Declan began his career in PricewaterhouseCoopers in Dublin and subsequently worked in PricewaterhouseCoopers in London and BDO in Dublin.
A fellow of the Institute of Chartered Accountants in Ireland, Declan has a Bachelor Science degree in Management Science & Industrial System Studies from Trinity College, Dublin and a Professional Diploma in Accounting from Dublin City University.